Multiple studies in colorectal, gastric, pancreas, non–small cell lung cancer have shown increased TAGLN expression is associated with migration, invasion, and poor survival (36–38); however, others have suggested it is a tumor suppressor in colorectal cancer (39). This evidence concerns the gene TAGLN and colorectal cancer.